Poolbeg Pharma PLC (AIM:POLB)
London · Delayed Price · Currency is GBP · Price in GBX 4.700
+0.100 (2.17%)
Feb 12, 2026, 4:37 PM GMT
Poolbeg Pharma Market Cap
Poolbeg Pharma has a market cap or net worth of 32.43 million as of February 12, 2026. Its market cap has increased by 27.20% in one year.
Market Cap
32.43M
Enterprise Value
22.47M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
4.70
Market Cap Chart
Since July 19, 2021, Poolbeg Pharma's market cap has decreased from 53.75M to 32.43M, a decrease of -39.66%. That is a compound annual growth rate of -10.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 32.43M | 16.30% |
| Dec 31, 2025 | 27.89M | -21.44% |
| Dec 31, 2024 | 35.50M | -21.55% |
| Dec 29, 2023 | 45.25M | 49.59% |
| Dec 30, 2022 | 30.25M | -36.32% |
| Dec 31, 2021 | 47.50M | -11.63% |
| Jul 19, 2021 | 53.75M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Faron Pharmaceuticals Oy | 77.58M |
| Hemogenyx Pharmaceuticals | 57.51M |
| SkinBioTherapeutics | 51.13M |
| hVIVO | 48.31M |
| Ondine Biomedical | 41.09M |
| ImmuPharma | 32.38M |
| Arecor Therapeutics | 28.70M |
| Aptamer Group | 25.62M |